Devyser Diagnostics AB (FRA:OL0) OCF Yield %: 1.79 (As of Jun. 29, 2026)


FRA:OL0 Devyser Diagnostics AB FRA:OL0
79 GF Score
Price €7.49
GF Value €13.58
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Devyser Diagnostics AB OCF Yield %?

Devyser Diagnostics AB FRA:OL0 -2.60% 79 OCF Yield % is 1.79 as of Jun. 29, 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 79/100 and a GF Value™ of €13.58 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Devyser Diagnostics AB ranks better than 50.29% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Devyser Diagnostics AB's Trailing 12-Month Cash Flow from Operations is €2.36 Mil, and Market Cap is €128.85 Mil. Therefore, Devyser Diagnostics AB's OCF Yield % for today is 1.79%.

The historical rank and industry rank for Devyser Diagnostics AB's OCF Yield % or its related term are showing as below:

FRA:OL0' s OCF Yield % Range Over the Past 10 Years
Min: -6.7   Med: -2.51   Max: 2.02
Current: 1.79


During the past 9 years, the highest OCF Yield % of Devyser Diagnostics AB was 2.02%. The lowest was -6.70%. And the median was -2.51%.

FRA:OL0's OCF Yield % is ranked better than
50.29% of 851 companies
in the Medical Devices & Instruments industry
Industry Median: 1.76 vs FRA:OL0: 1.79

Devyser Diagnostics AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Devyser Diagnostics AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Devyser Diagnostics AB OCF Yield % Related Terms


Devyser Diagnostics AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Devyser Diagnostics AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devyser Diagnostics AB OCF Yield % Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only -1.30 -3.57 -5.82 -2.66 0.43

Devyser Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.33 0.44 -0.09 2.47 3.91

FRA:OL0 vs ABT, SYK, MDT: OCF Yield % Comparison

For the Medical Devices subindustry, Devyser Diagnostics AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's OCF Yield % falls into.


FRA:OL0
79GF Score
Devyser Diagnostics AB FRA:OL0
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devyser Diagnostics AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Devyser Diagnostics AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=0.754 / 173.86776
=0.43%

Devyser Diagnostics AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=1.123 * 4 / 114.9816
=3.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 1.79 mean?
Devyser Diagnostics AB (FRA:OL0) has a OCF Yield % of 1.79 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Devyser Diagnostics AB and its competitors. According to the industry distribution chart, Devyser Diagnostics AB ranks #423 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 49.7%.
Is Devyser Diagnostics AB's OCF Yield % too high?
Devyser Diagnostics AB's current OCF Yield % is 1.79. The Medical Devices & Instruments industry median OCF Yield % is 1.76. Devyser Diagnostics AB's value of 1.79 is 1.7% above this industry median. Based on the distribution chart, Devyser Diagnostics AB ranks #423 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Devyser Diagnostics AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Devyser Diagnostics AB ranks #423 out of 851 companies for OCF Yield %. This puts Devyser Diagnostics AB in the upper half of its industry. The industry median OCF Yield % is 1.76. Devyser Diagnostics AB's value of 1.79 is 1.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Devyser Diagnostics AB's current OCF Yield % of 1.79 is 1.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Devyser Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devyser Diagnostics AB's current OCF Yield % is 1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.58, compared to a current price of €7.49 — trading 44.8% below its estimated fair value. The current OCF Yield % is 1.79 and 1.7% above the Medical Devices & Instruments industry median of 1.76. Devyser Diagnostics AB's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current OCF Yield % is 1.79 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?

Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued. The current stock price of €7.49 is trading 44.8% below its estimated GF Value™ of €13.58. GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.

Key valuation signals for FRA:OL0:

  • OCF Yield %: 1.79
  • GF Value™: €13.58 vs. price of €7.49 (44.8% below fair value)
  • GF Score™: 79/100 with 2 warning signs
  • Industry Position: 1.7% above the Medical Devices & Instruments median (#423 of 851)

No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Devyser Diagnostics AB Business Description

Other Exchanges DVYSR:Sweden
Address Branningevagen 12, Arsta, SWE, 120 54
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
79GF Score

Get the complete analysis for FRA:OL0

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.49
Price
€13.58
GF Value